- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04642066
Cold Water Immersion and Atherosclerosis, Inflammation, Fat Accumulation and Lipid Profile Parameters
Effect of Repeatedly Applied Cold Water Immersion on Subclinical Atherosclerosis, Inflammation, Fat Accumulation and Lipid Profile Parameters of Volunteers
The impact of the environment on human health is considerable. An important factor is the effect of temperature on the human body, where either the effects of short-term exposure to extreme temperatures (cryotherapy, sauna, etc.) or the long-term environmental impact are monitored.
The study was focused on research of the long-term effect of repeated CWI on atherogenesis, lipid parameters and fat distribution.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study was designed as a cohort observational studyfollowing the group of volunteers practicing CWI. Totally forty volunteers agreed to participate in the study by signing the informed consent, approved by the local ethics committee of UPJŠ Košice. Volunteers were examined in Cardiology and General Medicine outpatient clinics of Faculty of medicine, UPJŠ Košice (1st Department of Internal Medicine; outpatient clinics of Medicomp Košice Ltd.). They underwent the anamnesis and examination with a focus in the first step on matching the inclusion criteria: SCORE for the assessment of the cardiovascular risk as low (≤1%), patients without the suspected diagnosis of the familialhypercholesterolemia, respectively with TC level above 8 mmol/L, respectively TG concentrations above 2.3 mmol/L, male gender, age between 21 and 60, signed informed consent to participate in the study.
Patients with one or more exclusion criteria were not included: volunteers with lipid-lowering therapy or those that received hypolipidemics in the period shorter than 3 months before the study, values of blood lipids outside the inclusion criteria, glucose intolerance and DM,presence of advanced cardiovascular (plague or coronary artery disease, TIA, stroke, etc.) or chronic inflammatory diseases, infection or diseases possible affecting measured parameters and significant lifestyle changes in the last period of 6 months before the CWI.
After the initial examination, 35 volunteers fulfilled the criteria. Volunteers of the study underwent controlled, repeated CWI (5 months 15/11/18 - 15/03/19)based on a following pre-prepared protocol in the cooperation of our physicians and the sport club: Full body CWI in open standing, except the head (same location, timing), frequency three times a weekin the duration of 7-10 minutes. Swimming was permitted. Volunteers must not use neoprene aids (gloves, shoes), caps were allowed. Volunteers should be in the final phase submerged in water, above which there should only be the head and neck. The upper limbs were below the water surface. Non-neoprene footwear was permitted. Volunteers entered the water continuously without stopping. The time of stay in water was calculated from the first contact of the foot with water. On average, the whole body needed to be immersed in water within 30 seconds. The entire study was performed in the nearby lake, where all participants in the active arm were exposed to the same weather and water conditions, which were monitored. Volunteers who did not follow the protocol in more than 15% of the episodes, respectively, with weight, fat or muscle mass changes over 5%, with significant dietary changes were excluded from the study. Equivalent sham control group (N=30) was included fulfilling the inclusion criteria, without the CWI.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Stefan Tóth, MUDr., PhD
- Phone Number: 00421918038
- Email: stefan.toth@upjs.sk
Study Locations
-
-
-
Košice, Slovakia, 04011
- 1st Department of Internal medicine, L. Pasteur University Hospital in Košice
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
without cardiovascular and metabolic disease cold water immersion
Exclusion Criteria:
cancer inflammatory diseases cardovascular diseases tuberculosis renal and hepatic insufficiency pregnancy cardiovascular diseases obesity metabolic syndrome lymphoproliferative disorders liver transplantation in the past suspected. chronic infection in risk locations
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Active Group
Healthy volunteers were followed during the 5-month CWI exposition under standard conditions (three times per week 7-10 min).
Neoprene equipment was not allowed; volunteers with followed weight or muscle mass changes over 5% were excluded
|
Full body CWI in open standing, except the head (same location, timing), frequency three times a week in the duration of 7-10 minutes.
Swimming was permitted.
Volunteers must not use neoprene aids (gloves, shoes), caps were allowed.
Volunteers should be in the final phase submerged in water, above which there should only be the head and neck.
The upper limbs were below the water surface.
Non-neoprene footwear was permitted.
Volunteers entered the water continuously without stopping.
The time of stay in water was calculated from the first contact of the foot with water.
On average, the whole body needed to be immersed in water within 30 seconds.
|
Sham Comparator: Sham control
Control without CWI exposition
|
People without cold water immersion
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Body mass index
Time Frame: 6 months
|
BMI kg/m2
|
6 months
|
Change in total cholesterol from baseline
Time Frame: 6 months
|
percentual change in total cholesterol (mmoL/L)
|
6 months
|
Concentrations of PCSK9, hsCRP and other inflammation markers
Time Frame: 6 months
|
mmol/l
|
6 months
|
cIMT
Time Frame: 6 months
|
mm
|
6 months
|
PWV
Time Frame: 6 months
|
m/s
|
6 months
|
Beta
Time Frame: 6 months
|
6 months
|
|
AU
Time Frame: 6 months
|
6 months
|
|
SF
Time Frame: 6 months
|
mm
|
6 months
|
VF
Time Frame: 6 months
|
mm
|
6 months
|
Fatty acid profile
Time Frame: 6 months
|
mol/l
|
6 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Stefan Tóth, MUDr., PhD, Pavol Joef Safárik University, Faculty of Medicine
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- LF UPJS
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Immune System Diseases
-
University of HelsinkiTampere UniversityCompletedImmune System DisordersFinland
-
Kadmon, a Sanofi CompanyCompletedImmune System Disorder (Healthy Volunteers)United States
-
Kadmon, a Sanofi CompanyCompletedImmune System Disorder (Healthy Volunteer)United States
-
Kadmon, a Sanofi CompanyCompletedImmune System Disorder (Healthy Volunteer)United States
-
Kadmon, a Sanofi CompanyCompletedImmune System Disorder (Healthy Volunteer)United States
-
SanofiTerminatedImmune System DisorderUnited States, Spain
-
National Heart, Lung, and Blood Institute (NHLBI)National Cancer Institute (NCI); Blood and Marrow Transplant Clinical Trials...CompletedGraft vs Host Disease | Immune System DisordersUnited States
-
Shanghai Henlius BiotechCompleted
-
University Hospital, LimogesCompleted
-
University Hospital, LilleLaboratoire français de Fractionnement et de BiotechnologiesCompleted
Clinical Trials on Cold water immersion
-
Universidade Federal do Rio Grande do NorteUnknown
-
Gazi UniversityNot yet recruiting
-
Taipei Medical UniversityCompletedGout ArthritisIndonesia
-
Universität des SaarlandesCompleted
-
Paulista UniversityCompleted
-
Flávia CarvalhoNot yet recruitingMovement Disorders | Muscle Tone
-
Iraia Bidaurrazaga-LetonaCompleted
-
Centre Hospitalier Universitaire de BesanconCompletedRheumatoid Arthritis | Physical Activity | Cryotherapy EffectFrance
-
LUCIANA MARIA MALOSA SAMPAIOUnknownFatigue | Recovery | Oxidative Stress | Soccer | Cold Water Immersion | Photobiomodulation Therapy
-
Scheila Marisa PinheiroCompletedAthletic Performance